Company intelligence / Profile preview

A4CELL

Madrid,, Madrid,, Madrid,a4cell.com ↗

Ownership: Private
Development stage: Commercial

Overview

A4CELL has developed SPAchip® technology—intracellular silicon microchips that can be internalized into living cells to monitor cellular pathways in real time using fluorescent probes. Their products enable high-content imaging and analysis of live single cells to accelerate drug discovery and reduce reliance on animal models. The company recently secured €3 million in investment to expand R&D efforts.[1][2][3]

No clinical results as the company does not develop therapeutics but provides enabling technologies.

Therapeutic areas: Oncology
Modalities: Not directly therapeutic; provides technology for cell-based assays and live-cell analysis (enabling work with small molecules, biologics, etc. by customers)[1][3][4]
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on A4CELL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on A4CELL.

Explore the full profile